Stock listing
C17 Stock Price, News, Filings & Events — Corvus Pharmaceuticals, Inc.
Selected listing: C17 · HAM · EUR · DE
This page tracks Corvus Pharmaceuticals, Inc.'s C17:HAM listing on HAM in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following C17:HAM. C17:HAM is the stock-level entry point for investors researching Corvus Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Corvus Pharmaceuticals, Inc. (Ticker: CRVS) is a publicly traded company based in the United States, focusing on the development of innovative therapies for cancer treatment. With a market capitalization of approximately $1.1 billion, Corvus is dedicated to advancing its research and clinical programs to improve patient outcomes in oncology. The company is committed to addressing unmet medical needs through its unique approach to...
- Ticker
- C17:HAM
- Asset type
- Stock
- Market cap
- $1.19B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- HAM
- Currency
- EUR
Corvus Pharmaceuticals, Inc. C17:HAM stock context
This page tracks Corvus Pharmaceuticals, Inc.'s C17:HAM listing on HAM in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following C17:HAM. C17:HAM is the stock-level entry point for investors researching Corvus Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Corvus Pharmaceuticals, Inc. (Ticker: CRVS) is a publicly traded company based in the United States, focusing on the development of innovative therapies for cancer treatment. With a market capitalization of approximately $1.1 billion, Corvus is dedicated to advancing its research and clinical programs to improve patient outcomes in oncology. The company is committed to addressing unmet medical needs through its unique approach to...
Latest news from Corvus Pharmaceuticals, Inc.
Corvus Pharmaceuticals Announces Publication in Blood of Final Phase 1 Data from the Soquelitinib Phase 1/1b T Cell Lymphoma Trial
August 27, 2026
Corvus Pharmaceuticals to Provide Business Update and Second Quarter 2026 Financial Results on August 6, 2026
July 30, 2026
Corvus Pharmaceuticals Announces Additional Investment in Angel Pharmaceuticals to Advance the Development of Soquelitinib in China
June 9, 2026
Corvus Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference and Goldman Sachs 47th Annual Global Healthcare Conf...
May 20, 2026
Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2026 Financial Results
May 7, 2026
Corvus Pharmaceuticals, Inc. earnings calls
Corvus Pharmaceuticals, Inc. (CRVS) Q2 2026 Earnings Call
August 6, 2026 · Replay with transcript and chapters
Corvus Pharmaceuticals, Inc. (CRVS) Q4 2025 Earnings Call
March 12, 2026 · Replay with transcript and chapters
Corvus Pharmaceuticals, Inc. (CRVS) Q3 2025 Earnings Call
November 4, 2025 · Replay with transcript and chapters
Corvus Pharmaceuticals, Inc. (CRVS) Q2 2025 Earnings Call
August 7, 2025 · Replay with transcript and chapters
Corvus Pharmaceuticals, Inc. (CRVS) Q1 2025 Earnings Call
May 8, 2025 · Replay with transcript and chapters
Corvus Pharmaceuticals, Inc. (CRVS) Q4 2024 Earnings Call
March 25, 2025 · Replay with transcript and chapters
Research Corvus Pharmaceuticals, Inc.
Corvus Pharmaceuticals, Inc. investor report
Review AI stock analysis and investor report context for C17:HAM.
Corvus Pharmaceuticals, Inc. company profile
View the public company page for Corvus Pharmaceuticals, Inc. on 6ix.
Corvus Pharmaceuticals, Inc. news
Read company news and market updates connected to Corvus Pharmaceuticals, Inc..
Corvus Pharmaceuticals, Inc. investor events
Find investor webinars, events, and replay context for Corvus Pharmaceuticals, Inc..
Alternate listings
CRVS:NASDAQ
US · USD
Alternate listing for Corvus Pharmaceuticals, Inc.; the primary context on this page is C17:HAM.
C17:GETTEX
DE · EUR
Alternate listing for Corvus Pharmaceuticals, Inc.; the primary context on this page is C17:HAM.
A2AFXS:LSX
DE · EUR
Alternate listing for Corvus Pharmaceuticals, Inc.; the primary context on this page is C17:HAM.
A2AFXS:LS
DE · EUR
Alternate listing for Corvus Pharmaceuticals, Inc.; the primary context on this page is C17:HAM.
C17:TRADEGATE
DE · EUR
Alternate listing for Corvus Pharmaceuticals, Inc.; the primary context on this page is C17:HAM.
CRVS:BOATS
US · USD
Alternate listing for Corvus Pharmaceuticals, Inc.; the primary context on this page is C17:HAM.
C17:DUS
DE · EUR
Alternate listing for Corvus Pharmaceuticals, Inc.; the primary context on this page is C17:HAM.
C17:FWB
DE · EUR
Alternate listing for Corvus Pharmaceuticals, Inc.; the primary context on this page is C17:HAM.
C17:MUN
DE · EUR
Alternate listing for Corvus Pharmaceuticals, Inc.; the primary context on this page is C17:HAM.
C17:BX
CH · CHF
Alternate listing for Corvus Pharmaceuticals, Inc.; the primary context on this page is C17:HAM.
C17:SWB
DE · EUR
Alternate listing for Corvus Pharmaceuticals, Inc.; the primary context on this page is C17:HAM.